Biomaven, thanks for helping me develop the conviction to hold on to ARIA.
Eerily, the Brigatinib comments on Takeda's CC by CSO/CMO Andrew Plumb were almost xerox copies of blurbs Peter has written on this board and elsewhere.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”